Vaccines are being tested worldwide to avoid the dangers of the corona epidemic (Covid-19 Pandemic). Apart from this, policies are being prepared to make it available to every person. In such a new diplomacy has emerged. India, Bangladesh and Myanmar will cooperate with each other in the development of the corona vaccine. It will promote the country’s ‘first neighbor’ and ‘Act East Policy’. Top officials from the Ministry of Foreign Affairs (MEA) and related agencies negotiated with the government of Bangladesh and Myanmar on joint production, distribution and supply of the vaccine.
There have been two training modules so far
In an interaction with Financial Express Online, MEA’s official spokesperson Anurag Shrivastava said that two training modules have been organized with neighboring countries so far. About 90 health experts and scientists have also participated in it. He said that if other countries want to participate in this program, then this scheme will be extended. In September, Prime Minister Modi said in the United Nations General Assembly that India will help all countries to increase cold chain and storage capacity by supplying vaccines.
Also read- Vaccine will come by June next year
Also offer cooperation with other countries
According to the MEA spokesperson, on October 17-19, a delegation went to Bangladesh to discuss the current phase of the vaccine. Both sides held talks on the outline of the clinical trial in Bangladesh. In this case, virtual infraction has taken place with Myanmar. On a trial basis, India will collaborate with other countries for clinical trial, capacity building for vaccine development and then for its production and supply. A senior officer said that India will produce more than 60 percent of the vaccine worldwide and once the approval of scientists is given, it will be prepared on a large scale. After this it will be supplied first to neighbors and then to other countries.
India’s diplomatic victory
Speaking to Financial Express Online, senior journalist and Bangladesh commentator Gautam Lahiri says that this is India’s diplomatic victory in vaccine diplomacy. Bangladesh has agreed on the clinical trial of the Indian vaccine. China offered financial support to Bangladesh for the trial of the Corona vaccine made by Synovac Biotech Limited, but Bangladesh rejected it. Bangladesh-based company Beximo Forma has tied up with India’s Serum Institute of India for vaccine supply on a priority basis.
Talks with Mexico continue
Recently there was a high-level meeting between India and Mexicans. In this, both sides exchanged their notes about vaccine development. The source has revealed to Finance Express Online that India has asked the Government of Mexico to consider the Procurement of Pharma. In addition, there will be a virtual meeting on vaccine and pandemic management in November under the India-Mexico Program of Corporation 2020-2022.